Did the GAO Miss the Boat on DTC Genetic Testing?

Aug 20, 2010

Genomes Unzipped's Luke Jostins, Katherine Morley, and Daniel MacArthur say the GAO's sting on the DTC genetic testing industry was a "missed opportunity" to systematically evaluate the industry and find ways to make it better.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

HudsonAlpha Health Alliance, Auburn University Form Genetic Testing Partnership
Amazon to Give Out $12M Under Next Phase of AWS Diagnostics Development Initiative
Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings
Top Five Articles on GenomeWeb Last Week: Invitae, Cancer, Illumina, and More
Genomenon, Limbus Medical to Integrate Technologies for Clinical Variant Interpretation
Lucira Health Nabs OTC EUA for SARS-CoV-2 Test, Expects Q1 Revenues of up to $4.5M

The Scan

Hurdles to Genomic Surveillance

Nature News writes that viral genomic surveillance in the US faces systemic issues.

Boosts Requested

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

Early Trial Responses

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

PLOS Papers on Chronic Pain, Indigenous Populations in Mexico, SARS-CoV-2 Mutations

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.

Menu